🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

UnitedHealth To Buy Advisory Board's Health Care Business

Published 08/31/2017, 08:05 AM
Updated 07/09/2023, 06:31 AM
US500
-
AET
-
UNH
-
ABCO
-
WCG
-

Health insurer, UnitedHealth Group Inc.’s (NYSE:UNH) health services unit Optum has announced that it will acquire the health care business of The Advisory Board Company (NASDAQ:ABCO) .

The buyout will bolster the company’s population health management business which includes aggregation of patient data across multiple health information technology resources along with the analysis of that data into a single, actionable patient record. This synthesized data can then be used to improve both clinical and financial outcomes.

Further, the acquisition is believed to be strategically attractive for Optum as it will provide cross-selling opportunities and diversification benefits.

UnitedHealth has chosen Advisory Board owing to its strong market reputation, and large and important client base in its Health Care segment.

Advisory Board health care segment provides three services — research, technology and consulting. These services combined with Optum’s unmatched data analytics resources, investment capacities and operational experience will help it to better serve members and clients.

UnitedHealth aims to make it big in the market for population health management which is anticipated to grow significantly in the coming years.

The need for population health management is becoming imperative as the healthcare payment system moves from the one based on fee-for-service and volume of patients served to one based on value, improvements in patient health, and associated decreases in healthcare costs.

Consequently, we will not be surprised to see other players in the industry expanding or deploying population health management program.

The board of directors of Advisory Board has approved the merger agreement. The deal valued at nearly $1.3 billion is expected to conclude in late 2017 or early 2018. However, post completion it will not be accretive to earnings in the first year.

In past year shares of UnitedHealth have returned 44.6%, higher than the industry’s gain of 42.6%.

UnitedHealth’s Optum business is a jewel in its crown. It remains a strong revenues and earnings growth driver. The segment provides immense diversification benefits to the company and is expected to generate long-term earnings growth in the high-teens.

Management is considering the expansion of the health service business to generate 30-40% of operating income over the longer term and has been making acquisitions in the area. Moreover, the company is under-penetrated in the health service area and that investments in this field will reap benefits over the long term.

UnitedHealth carries a Zacks Rank #3 (Hold). Some better-ranked players in the same space are Aetna Inc. (NYSE:AET) and WellCare Health Plans, Inc. (NYSE:WCG) . Both these stocks carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Aetna, one of the largest health benefits company, beat estimates in each of the last four quarters with an average positive surprise of 19%.

WellCare Health Plans provides managed care services targeted exclusively at government-sponsored healthcare programs. It beat estimates in all the trailing four quarters with an average positive surprise of 47.4%.

One Simple Trading Idea

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.

Learn more >>



Aetna Inc. (AET): Free Stock Analysis Report

UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

WellCare Health Plans, Inc. (WCG): Free Stock Analysis Report

The Advisory Board Company (ABCO): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.